—
Gentech Pharmaceutical (GP) has been well established as a global leader in the world of non-prescription pharmaceuticals with distribution in 47 countries. Their products include PhenTabz for weight loss, ADDTabz used as an Adderall alternative for millions and REMTabz for insomnia. The company has a significant amount of hospitals, medical clinics, medical franchises and innumerable individual physician offices distributing their RX versions throughout the US, UK and Europe and also has one of the largest online sales platforms in the pharmaceutical world generating millions of dollars to their bottom line. “We were very pleased with Lexium International’s infrastructure, growth strategy and financial stability. We are have complete confidence in their ability to continue to grow Gentech and serve our global patient and customer base” said former Gentech CEO and founder Derek Vest.
Lexium International is known for its R&D capabilities and a strong network of global distributors. Last year Lexium structured a take-over strategy to purchase GP and all its intellectual property and distribution outlets. The process of name change started last year and the final sale occurred during the first half of this year.
Industry insiders see this as a strong play for Lexium International and an easy conduit to bring its own product pipeline out to a massive loyal consumer base. Additionally, Lexium used their designer pharmacological expertise to improve on the GP product suite by increasing potency and efficacy via reformulation and enhanced molecular processes. “We knew we had the capability of improving upon the formulations and set about giving enhanced benefits to our loyal customer base without increasing price points” said CEO, Tara Vest. “We have another game-changing OTC product coming out next quarter that will shake up the pharmaceutical world and really show off our DNA in science based nutrition” continued Ms. Vest.
About Lexium International: Lexium is a pharmaceutical company that develops and commercializes proprietary products using non-prescription pharmaceuticals in the areas of Weight Loss, ADD, Mental Enhancement, Diabetes, Anxiety/Stress Relief, Sexual Dysfunction and Anti-Aging. Lexium has offices in the US and UK with distribution into 47+ countries.
Release ID: 93404